A saliva test that diagnoses mouth and throat cancer caused by HPV could save thousands of lives each year, a study suggests.
Scientists at Duke University in North Carolina discovered the test was 80 per cent accurate at spotting the killer diseases.
Doctors say it is able to detect the cancers early on, giving patients much higher hopes of surviving their battle.
Before it can be used in hospitals around the world, further trials will be needed to confirm the technology works.
But the researchers are hopeful, claiming the cheaper test - which gives results in as little as 10 minutes - has significant 'potential'.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
Clue:
ReplyDeleteIf you never accept the HPV vaccine, you will never contract HPV
You're welcome
huh, too bad they didn't come up with this before they injected millions of kids with gardasil.
ReplyDeletea whole generation poisoned for $$ and we won't know the consequences for decades
Not like they haven't done this before:
A popular anti-miscarriage drug used between 1940 and 1960 has been linked to breast cancer, infertility, and a host of other health problems in the daughters of women who used it while pregnant, according to a study in The New England Journal of Medicine
. Researchers even suspect it could cause reproductive health issues in the granddaughters of women who used it
. What was this drug? And who's at risk now? Here's what you should know:
What is it?
The drug — DES, or diethylstilbestrol — is a synthetic form of estrogen that was often prescribed in the United States and Europe. It was intended to help pregnant women avoid miscarriages and premature childbirth. DES was discontinued in 1971 when studies found not only that it didn't work, but that women whose mothers had taken the drug had a higher risk of a rare kind of vaginal cancer and 11 other reproductive issues, including infertility, spontaneous abortion, neonatal death, and invasive breast cancer.